nodes	percent_of_prediction	percent_of_DWPC	metapath
Acetylcysteine—ACY1—renal system—uterine cancer	0.014	0.0574	CbGeAlD
Acetylcysteine—Throat tightness—Progesterone—uterine cancer	0.0124	0.0366	CcSEcCtD
Acetylcysteine—ACY1—female reproductive system—uterine cancer	0.0112	0.046	CbGeAlD
Acetylcysteine—CHUK—epithelium—uterine cancer	0.0104	0.0428	CbGeAlD
Acetylcysteine—CHUK—renal system—uterine cancer	0.00969	0.0397	CbGeAlD
Acetylcysteine—IKBKB—myometrium—uterine cancer	0.00905	0.037	CbGeAlD
Acetylcysteine—GSS—myometrium—uterine cancer	0.00888	0.0363	CbGeAlD
Acetylcysteine—SLC7A11—smooth muscle tissue—uterine cancer	0.00829	0.0339	CbGeAlD
Acetylcysteine—SLC7A11—renal system—uterine cancer	0.00798	0.0327	CbGeAlD
Acetylcysteine—CHUK—female reproductive system—uterine cancer	0.00776	0.0318	CbGeAlD
Acetylcysteine—CHUK—female gonad—uterine cancer	0.00706	0.0289	CbGeAlD
Acetylcysteine—IKBKB—uterine cervix—uterine cancer	0.00704	0.0288	CbGeAlD
Acetylcysteine—GSS—uterine cervix—uterine cancer	0.00691	0.0283	CbGeAlD
Acetylcysteine—IKBKB—smooth muscle tissue—uterine cancer	0.00684	0.028	CbGeAlD
Acetylcysteine—GSS—smooth muscle tissue—uterine cancer	0.00672	0.0275	CbGeAlD
Acetylcysteine—IKBKB—decidua—uterine cancer	0.00671	0.0275	CbGeAlD
Acetylcysteine—GSS—decidua—uterine cancer	0.00658	0.0269	CbGeAlD
Acetylcysteine—GSS—renal system—uterine cancer	0.00646	0.0265	CbGeAlD
Acetylcysteine—SLC7A11—female reproductive system—uterine cancer	0.00639	0.0262	CbGeAlD
Acetylcysteine—IKBKB—endometrium—uterine cancer	0.00637	0.0261	CbGeAlD
Acetylcysteine—Throat tightness—Etoposide—uterine cancer	0.00635	0.0187	CcSEcCtD
Acetylcysteine—GSS—endometrium—uterine cancer	0.00625	0.0256	CbGeAlD
Acetylcysteine—Gait disturbance—Progesterone—uterine cancer	0.00623	0.0184	CcSEcCtD
Acetylcysteine—IKBKB—mammalian vulva—uterine cancer	0.00616	0.0252	CbGeAlD
Acetylcysteine—GSS—mammalian vulva—uterine cancer	0.00605	0.0247	CbGeAlD
Acetylcysteine—IKBKB—uterus—uterine cancer	0.00587	0.024	CbGeAlD
Acetylcysteine—SLC7A11—female gonad—uterine cancer	0.00581	0.0238	CbGeAlD
Acetylcysteine—GSS—uterus—uterine cancer	0.00576	0.0236	CbGeAlD
Acetylcysteine—GRIN2A—vagina—uterine cancer	0.00535	0.0219	CbGeAlD
Acetylcysteine—Mental disability—Progesterone—uterine cancer	0.00528	0.0156	CcSEcCtD
Acetylcysteine—IKBKB—female reproductive system—uterine cancer	0.00527	0.0216	CbGeAlD
Acetylcysteine—GSS—female reproductive system—uterine cancer	0.00518	0.0212	CbGeAlD
Acetylcysteine—Ear pain—Progesterone—uterine cancer	0.00518	0.0153	CcSEcCtD
Acetylcysteine—Sensitisation—Epirubicin—uterine cancer	0.00488	0.0144	CcSEcCtD
Acetylcysteine—IKBKB—female gonad—uterine cancer	0.0048	0.0196	CbGeAlD
Acetylcysteine—IKBKB—vagina—uterine cancer	0.00477	0.0195	CbGeAlD
Acetylcysteine—SLCO1B1—renal system—uterine cancer	0.00475	0.0194	CbGeAlD
Acetylcysteine—GSS—female gonad—uterine cancer	0.00471	0.0193	CbGeAlD
Acetylcysteine—GSS—vagina—uterine cancer	0.00468	0.0192	CbGeAlD
Acetylcysteine—Anaphylactoid reaction—Progesterone—uterine cancer	0.00456	0.0135	CcSEcCtD
Acetylcysteine—CHUK—lymph node—uterine cancer	0.00454	0.0186	CbGeAlD
Acetylcysteine—Sensitisation—Doxorubicin—uterine cancer	0.00452	0.0133	CcSEcCtD
Acetylcysteine—Face oedema—Progesterone—uterine cancer	0.00426	0.0126	CcSEcCtD
Acetylcysteine—Anaphylactoid reaction—Medroxyprogesterone Acetate—uterine cancer	0.00413	0.0122	CcSEcCtD
Acetylcysteine—Nasopharyngitis—Progesterone—uterine cancer	0.00395	0.0117	CcSEcCtD
Acetylcysteine—Face oedema—Medroxyprogesterone Acetate—uterine cancer	0.00386	0.0114	CcSEcCtD
Acetylcysteine—Asthma—Progesterone—uterine cancer	0.00382	0.0113	CcSEcCtD
Acetylcysteine—SLCO1B1—female reproductive system—uterine cancer	0.00381	0.0156	CbGeAlD
Acetylcysteine—Nasopharyngitis—Medroxyprogesterone Acetate—uterine cancer	0.00358	0.0106	CcSEcCtD
Acetylcysteine—Chest discomfort—Etoposide—uterine cancer	0.00352	0.0104	CcSEcCtD
Acetylcysteine—Asthma—Medroxyprogesterone Acetate—uterine cancer	0.00346	0.0102	CcSEcCtD
Acetylcysteine—Drowsiness—Progesterone—uterine cancer	0.0034	0.01	CcSEcCtD
Acetylcysteine—Bronchospasm—Medroxyprogesterone Acetate—uterine cancer	0.0034	0.01	CcSEcCtD
Acetylcysteine—Body temperature increased—Carboplatin—uterine cancer	0.00327	0.00964	CcSEcCtD
Acetylcysteine—IKBKB—lymph node—uterine cancer	0.00309	0.0126	CbGeAlD
Acetylcysteine—Drowsiness—Medroxyprogesterone Acetate—uterine cancer	0.00308	0.0091	CcSEcCtD
Acetylcysteine—Pharyngitis—Progesterone—uterine cancer	0.00303	0.00895	CcSEcCtD
Acetylcysteine—GSS—lymph node—uterine cancer	0.00303	0.0124	CbGeAlD
Acetylcysteine—Stomatitis—Medroxyprogesterone Acetate—uterine cancer	0.00301	0.00887	CcSEcCtD
Acetylcysteine—Sweating—Medroxyprogesterone Acetate—uterine cancer	0.00296	0.00873	CcSEcCtD
Acetylcysteine—Cardiac disorder—Progesterone—uterine cancer	0.00284	0.00837	CcSEcCtD
Acetylcysteine—Angiopathy—Progesterone—uterine cancer	0.00277	0.00818	CcSEcCtD
Acetylcysteine—Immune system disorder—Progesterone—uterine cancer	0.00276	0.00815	CcSEcCtD
Acetylcysteine—Mediastinal disorder—Progesterone—uterine cancer	0.00275	0.00813	CcSEcCtD
Acetylcysteine—Pharyngitis—Medroxyprogesterone Acetate—uterine cancer	0.00275	0.00811	CcSEcCtD
Acetylcysteine—Erythema—Progesterone—uterine cancer	0.00266	0.00785	CcSEcCtD
Acetylcysteine—Cardiac disorder—Medroxyprogesterone Acetate—uterine cancer	0.00257	0.00759	CcSEcCtD
Acetylcysteine—Angiopathy—Medroxyprogesterone Acetate—uterine cancer	0.00251	0.00742	CcSEcCtD
Acetylcysteine—Immune system disorder—Medroxyprogesterone Acetate—uterine cancer	0.0025	0.00738	CcSEcCtD
Acetylcysteine—Mediastinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.00249	0.00737	CcSEcCtD
Acetylcysteine—Angioedema—Progesterone—uterine cancer	0.00243	0.00717	CcSEcCtD
Acetylcysteine—Erythema—Medroxyprogesterone Acetate—uterine cancer	0.00241	0.00711	CcSEcCtD
Acetylcysteine—Syncope—Progesterone—uterine cancer	0.00238	0.00704	CcSEcCtD
Acetylcysteine—Haemoptysis—Epirubicin—uterine cancer	0.00236	0.00696	CcSEcCtD
Acetylcysteine—Stomatitis—Dactinomycin—uterine cancer	0.00234	0.00692	CcSEcCtD
Acetylcysteine—Loss of consciousness—Progesterone—uterine cancer	0.00234	0.0069	CcSEcCtD
Acetylcysteine—Anaphylactoid reaction—Etoposide—uterine cancer	0.00233	0.00689	CcSEcCtD
Acetylcysteine—Cough—Progesterone—uterine cancer	0.00232	0.00685	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Progesterone—uterine cancer	0.00225	0.00664	CcSEcCtD
Acetylcysteine—Feeling hot—Epirubicin—uterine cancer	0.00222	0.00656	CcSEcCtD
Acetylcysteine—Angioedema—Medroxyprogesterone Acetate—uterine cancer	0.0022	0.0065	CcSEcCtD
Acetylcysteine—Haemoptysis—Doxorubicin—uterine cancer	0.00218	0.00644	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Progesterone—uterine cancer	0.00217	0.00641	CcSEcCtD
Acetylcysteine—Oedema—Progesterone—uterine cancer	0.00217	0.00641	CcSEcCtD
Acetylcysteine—Syncope—Medroxyprogesterone Acetate—uterine cancer	0.00216	0.00638	CcSEcCtD
Acetylcysteine—Pharyngitis—Dactinomycin—uterine cancer	0.00214	0.00633	CcSEcCtD
Acetylcysteine—Shock—Progesterone—uterine cancer	0.00214	0.0063	CcSEcCtD
Acetylcysteine—Tachycardia—Progesterone—uterine cancer	0.00212	0.00625	CcSEcCtD
Acetylcysteine—Loss of consciousness—Medroxyprogesterone Acetate—uterine cancer	0.00212	0.00625	CcSEcCtD
Acetylcysteine—Skin disorder—Progesterone—uterine cancer	0.00211	0.00622	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Progesterone—uterine cancer	0.0021	0.00619	CcSEcCtD
Acetylcysteine—Feeling hot—Doxorubicin—uterine cancer	0.00206	0.00607	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Medroxyprogesterone Acetate—uterine cancer	0.00204	0.00602	CcSEcCtD
Acetylcysteine—Hypotension—Progesterone—uterine cancer	0.00203	0.00599	CcSEcCtD
Acetylcysteine—Flushing—Dactinomycin—uterine cancer	0.002	0.00592	CcSEcCtD
Acetylcysteine—Oedema—Medroxyprogesterone Acetate—uterine cancer	0.00197	0.00581	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Medroxyprogesterone Acetate—uterine cancer	0.00197	0.00581	CcSEcCtD
Acetylcysteine—Dyspnoea—Progesterone—uterine cancer	0.00193	0.00571	CcSEcCtD
Acetylcysteine—Shock—Medroxyprogesterone Acetate—uterine cancer	0.00193	0.00571	CcSEcCtD
Acetylcysteine—Somnolence—Progesterone—uterine cancer	0.00193	0.0057	CcSEcCtD
Acetylcysteine—Bronchospasm—Etoposide—uterine cancer	0.00192	0.00567	CcSEcCtD
Acetylcysteine—Tachycardia—Medroxyprogesterone Acetate—uterine cancer	0.00192	0.00567	CcSEcCtD
Acetylcysteine—Dyspepsia—Progesterone—uterine cancer	0.00191	0.00564	CcSEcCtD
Acetylcysteine—Skin disorder—Medroxyprogesterone Acetate—uterine cancer	0.00191	0.00564	CcSEcCtD
Acetylcysteine—Thinking abnormal—Epirubicin—uterine cancer	0.00191	0.00563	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Medroxyprogesterone Acetate—uterine cancer	0.0019	0.00561	CcSEcCtD
Acetylcysteine—Erythema—Dactinomycin—uterine cancer	0.00188	0.00555	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Progesterone—uterine cancer	0.00187	0.00553	CcSEcCtD
Acetylcysteine—Hypotension—Medroxyprogesterone Acetate—uterine cancer	0.00184	0.00543	CcSEcCtD
Acetylcysteine—Gait disturbance—Epirubicin—uterine cancer	0.00179	0.00528	CcSEcCtD
Acetylcysteine—Thinking abnormal—Doxorubicin—uterine cancer	0.00176	0.00521	CcSEcCtD
Acetylcysteine—Dyspnoea—Medroxyprogesterone Acetate—uterine cancer	0.00175	0.00518	CcSEcCtD
Acetylcysteine—Somnolence—Medroxyprogesterone Acetate—uterine cancer	0.00175	0.00516	CcSEcCtD
Acetylcysteine—Dyspepsia—Medroxyprogesterone Acetate—uterine cancer	0.00173	0.00511	CcSEcCtD
Acetylcysteine—Urticaria—Progesterone—uterine cancer	0.00172	0.00509	CcSEcCtD
Acetylcysteine—Body temperature increased—Progesterone—uterine cancer	0.00172	0.00507	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.0017	0.00501	CcSEcCtD
Acetylcysteine—Stomatitis—Etoposide—uterine cancer	0.0017	0.00501	CcSEcCtD
Acetylcysteine—Gait disturbance—Doxorubicin—uterine cancer	0.00165	0.00488	CcSEcCtD
Acetylcysteine—Hypersensitivity—Progesterone—uterine cancer	0.0016	0.00472	CcSEcCtD
Acetylcysteine—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.00156	0.00461	CcSEcCtD
Acetylcysteine—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.00155	0.00459	CcSEcCtD
Acetylcysteine—Pruritus—Progesterone—uterine cancer	0.00154	0.00453	CcSEcCtD
Acetylcysteine—Oedema—Dactinomycin—uterine cancer	0.00153	0.00453	CcSEcCtD
Acetylcysteine—Mental disability—Epirubicin—uterine cancer	0.00151	0.00447	CcSEcCtD
Acetylcysteine—Flushing—Etoposide—uterine cancer	0.00145	0.00428	CcSEcCtD
Acetylcysteine—Cardiac disorder—Etoposide—uterine cancer	0.00145	0.00428	CcSEcCtD
Acetylcysteine—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.00145	0.00428	CcSEcCtD
Acetylcysteine—Dizziness—Progesterone—uterine cancer	0.00144	0.00424	CcSEcCtD
Acetylcysteine—Angiopathy—Etoposide—uterine cancer	0.00142	0.00419	CcSEcCtD
Acetylcysteine—Immune system disorder—Etoposide—uterine cancer	0.00141	0.00417	CcSEcCtD
Acetylcysteine—Mediastinal disorder—Etoposide—uterine cancer	0.00141	0.00416	CcSEcCtD
Acetylcysteine—Eye pain—Epirubicin—uterine cancer	0.0014	0.00414	CcSEcCtD
Acetylcysteine—Mental disability—Doxorubicin—uterine cancer	0.0014	0.00414	CcSEcCtD
Acetylcysteine—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.00139	0.00411	CcSEcCtD
Acetylcysteine—Vomiting—Progesterone—uterine cancer	0.00138	0.00407	CcSEcCtD
Acetylcysteine—Rash—Progesterone—uterine cancer	0.00137	0.00404	CcSEcCtD
Acetylcysteine—Dermatitis—Progesterone—uterine cancer	0.00137	0.00404	CcSEcCtD
Acetylcysteine—Anaphylactoid reaction—Epirubicin—uterine cancer	0.00131	0.00386	CcSEcCtD
Acetylcysteine—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.0013	0.00384	CcSEcCtD
Acetylcysteine—Eye pain—Doxorubicin—uterine cancer	0.0013	0.00383	CcSEcCtD
Acetylcysteine—Nausea—Progesterone—uterine cancer	0.00129	0.00381	CcSEcCtD
Acetylcysteine—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.00125	0.00369	CcSEcCtD
Acetylcysteine—Rash—Medroxyprogesterone Acetate—uterine cancer	0.00124	0.00366	CcSEcCtD
Acetylcysteine—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.00124	0.00366	CcSEcCtD
Acetylcysteine—Face oedema—Epirubicin—uterine cancer	0.00122	0.00361	CcSEcCtD
Acetylcysteine—Body temperature increased—Dactinomycin—uterine cancer	0.00121	0.00358	CcSEcCtD
Acetylcysteine—Anaphylactoid reaction—Doxorubicin—uterine cancer	0.00121	0.00357	CcSEcCtD
Acetylcysteine—Loss of consciousness—Etoposide—uterine cancer	0.0012	0.00353	CcSEcCtD
Acetylcysteine—Cough—Etoposide—uterine cancer	0.00119	0.0035	CcSEcCtD
Acetylcysteine—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.00117	0.00345	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.00115	0.0034	CcSEcCtD
Acetylcysteine—Nasopharyngitis—Epirubicin—uterine cancer	0.00113	0.00334	CcSEcCtD
Acetylcysteine—Face oedema—Doxorubicin—uterine cancer	0.00113	0.00334	CcSEcCtD
Acetylcysteine—Hypersensitivity—Dactinomycin—uterine cancer	0.00113	0.00334	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Etoposide—uterine cancer	0.00111	0.00328	CcSEcCtD
Acetylcysteine—Asthma—Epirubicin—uterine cancer	0.00109	0.00323	CcSEcCtD
Acetylcysteine—Tachycardia—Etoposide—uterine cancer	0.00108	0.0032	CcSEcCtD
Acetylcysteine—Skin disorder—Etoposide—uterine cancer	0.00108	0.00318	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Etoposide—uterine cancer	0.00107	0.00317	CcSEcCtD
Acetylcysteine—Nasopharyngitis—Doxorubicin—uterine cancer	0.00105	0.00309	CcSEcCtD
Acetylcysteine—Hypotension—Etoposide—uterine cancer	0.00104	0.00306	CcSEcCtD
Acetylcysteine—Asthma—Doxorubicin—uterine cancer	0.00101	0.00299	CcSEcCtD
Acetylcysteine—Dyspnoea—Etoposide—uterine cancer	0.00099	0.00292	CcSEcCtD
Acetylcysteine—Somnolence—Etoposide—uterine cancer	0.000987	0.00291	CcSEcCtD
Acetylcysteine—Drowsiness—Epirubicin—uterine cancer	0.000976	0.00288	CcSEcCtD
Acetylcysteine—Vomiting—Dactinomycin—uterine cancer	0.000975	0.00288	CcSEcCtD
Acetylcysteine—Rash—Dactinomycin—uterine cancer	0.000967	0.00286	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Etoposide—uterine cancer	0.000959	0.00283	CcSEcCtD
Acetylcysteine—Stomatitis—Epirubicin—uterine cancer	0.000951	0.00281	CcSEcCtD
Acetylcysteine—Sweating—Epirubicin—uterine cancer	0.000935	0.00276	CcSEcCtD
Acetylcysteine—Nausea—Dactinomycin—uterine cancer	0.000911	0.00269	CcSEcCtD
Acetylcysteine—Drowsiness—Doxorubicin—uterine cancer	0.000903	0.00267	CcSEcCtD
Acetylcysteine—Urticaria—Etoposide—uterine cancer	0.000882	0.0026	CcSEcCtD
Acetylcysteine—Stomatitis—Doxorubicin—uterine cancer	0.00088	0.0026	CcSEcCtD
Acetylcysteine—Body temperature increased—Etoposide—uterine cancer	0.000878	0.00259	CcSEcCtD
Acetylcysteine—Pharyngitis—Epirubicin—uterine cancer	0.000869	0.00257	CcSEcCtD
Acetylcysteine—Sweating—Doxorubicin—uterine cancer	0.000866	0.00256	CcSEcCtD
Acetylcysteine—Hypersensitivity—Etoposide—uterine cancer	0.000818	0.00242	CcSEcCtD
Acetylcysteine—Flushing—Epirubicin—uterine cancer	0.000813	0.0024	CcSEcCtD
Acetylcysteine—Cardiac disorder—Epirubicin—uterine cancer	0.000813	0.0024	CcSEcCtD
Acetylcysteine—Pharyngitis—Doxorubicin—uterine cancer	0.000804	0.00238	CcSEcCtD
Acetylcysteine—Angiopathy—Epirubicin—uterine cancer	0.000795	0.00235	CcSEcCtD
Acetylcysteine—Immune system disorder—Epirubicin—uterine cancer	0.000791	0.00234	CcSEcCtD
Acetylcysteine—Mediastinal disorder—Epirubicin—uterine cancer	0.000789	0.00233	CcSEcCtD
Acetylcysteine—Pruritus—Etoposide—uterine cancer	0.000786	0.00232	CcSEcCtD
Acetylcysteine—Erythema—Epirubicin—uterine cancer	0.000763	0.00225	CcSEcCtD
Acetylcysteine—Cardiac disorder—Doxorubicin—uterine cancer	0.000752	0.00222	CcSEcCtD
Acetylcysteine—Flushing—Doxorubicin—uterine cancer	0.000752	0.00222	CcSEcCtD
Acetylcysteine—Angiopathy—Doxorubicin—uterine cancer	0.000735	0.00217	CcSEcCtD
Acetylcysteine—Dizziness—Etoposide—uterine cancer	0.000734	0.00217	CcSEcCtD
Acetylcysteine—Immune system disorder—Doxorubicin—uterine cancer	0.000732	0.00216	CcSEcCtD
Acetylcysteine—Mediastinal disorder—Doxorubicin—uterine cancer	0.00073	0.00216	CcSEcCtD
Acetylcysteine—Vomiting—Etoposide—uterine cancer	0.000706	0.00208	CcSEcCtD
Acetylcysteine—Erythema—Doxorubicin—uterine cancer	0.000706	0.00208	CcSEcCtD
Acetylcysteine—Rash—Etoposide—uterine cancer	0.0007	0.00207	CcSEcCtD
Acetylcysteine—Dermatitis—Etoposide—uterine cancer	0.000699	0.00206	CcSEcCtD
Acetylcysteine—Syncope—Epirubicin—uterine cancer	0.000684	0.00202	CcSEcCtD
Acetylcysteine—Loss of consciousness—Epirubicin—uterine cancer	0.00067	0.00198	CcSEcCtD
Acetylcysteine—Cough—Epirubicin—uterine cancer	0.000665	0.00196	CcSEcCtD
Acetylcysteine—Nausea—Etoposide—uterine cancer	0.000659	0.00195	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000645	0.0019	CcSEcCtD
Acetylcysteine—Syncope—Doxorubicin—uterine cancer	0.000633	0.00187	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Epirubicin—uterine cancer	0.000622	0.00184	CcSEcCtD
Acetylcysteine—Oedema—Epirubicin—uterine cancer	0.000622	0.00184	CcSEcCtD
Acetylcysteine—Loss of consciousness—Doxorubicin—uterine cancer	0.00062	0.00183	CcSEcCtD
Acetylcysteine—Cough—Doxorubicin—uterine cancer	0.000616	0.00182	CcSEcCtD
Acetylcysteine—Shock—Epirubicin—uterine cancer	0.000612	0.00181	CcSEcCtD
Acetylcysteine—Tachycardia—Epirubicin—uterine cancer	0.000607	0.00179	CcSEcCtD
Acetylcysteine—Skin disorder—Epirubicin—uterine cancer	0.000605	0.00178	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Epirubicin—uterine cancer	0.000602	0.00178	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.000597	0.00176	CcSEcCtD
Acetylcysteine—Hypotension—Epirubicin—uterine cancer	0.000582	0.00172	CcSEcCtD
Acetylcysteine—Oedema—Doxorubicin—uterine cancer	0.000576	0.0017	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Doxorubicin—uterine cancer	0.000576	0.0017	CcSEcCtD
Acetylcysteine—Shock—Doxorubicin—uterine cancer	0.000567	0.00167	CcSEcCtD
Acetylcysteine—Tachycardia—Doxorubicin—uterine cancer	0.000562	0.00166	CcSEcCtD
Acetylcysteine—Skin disorder—Doxorubicin—uterine cancer	0.000559	0.00165	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Doxorubicin—uterine cancer	0.000557	0.00164	CcSEcCtD
Acetylcysteine—Dyspnoea—Epirubicin—uterine cancer	0.000555	0.00164	CcSEcCtD
Acetylcysteine—Somnolence—Epirubicin—uterine cancer	0.000553	0.00163	CcSEcCtD
Acetylcysteine—Dyspepsia—Epirubicin—uterine cancer	0.000548	0.00162	CcSEcCtD
Acetylcysteine—Hypotension—Doxorubicin—uterine cancer	0.000538	0.00159	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000537	0.00159	CcSEcCtD
Acetylcysteine—Dyspnoea—Doxorubicin—uterine cancer	0.000513	0.00152	CcSEcCtD
Acetylcysteine—Somnolence—Doxorubicin—uterine cancer	0.000512	0.00151	CcSEcCtD
Acetylcysteine—Dyspepsia—Doxorubicin—uterine cancer	0.000507	0.0015	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000497	0.00147	CcSEcCtD
Acetylcysteine—Urticaria—Epirubicin—uterine cancer	0.000494	0.00146	CcSEcCtD
Acetylcysteine—Body temperature increased—Epirubicin—uterine cancer	0.000492	0.00145	CcSEcCtD
Acetylcysteine—Hypersensitivity—Epirubicin—uterine cancer	0.000459	0.00135	CcSEcCtD
Acetylcysteine—Urticaria—Doxorubicin—uterine cancer	0.000457	0.00135	CcSEcCtD
Acetylcysteine—Body temperature increased—Doxorubicin—uterine cancer	0.000455	0.00134	CcSEcCtD
Acetylcysteine—Pruritus—Epirubicin—uterine cancer	0.00044	0.0013	CcSEcCtD
Acetylcysteine—Hypersensitivity—Doxorubicin—uterine cancer	0.000424	0.00125	CcSEcCtD
Acetylcysteine—Dizziness—Epirubicin—uterine cancer	0.000412	0.00122	CcSEcCtD
Acetylcysteine—Pruritus—Doxorubicin—uterine cancer	0.000407	0.0012	CcSEcCtD
Acetylcysteine—Vomiting—Epirubicin—uterine cancer	0.000396	0.00117	CcSEcCtD
Acetylcysteine—Rash—Epirubicin—uterine cancer	0.000392	0.00116	CcSEcCtD
Acetylcysteine—Dermatitis—Epirubicin—uterine cancer	0.000392	0.00116	CcSEcCtD
Acetylcysteine—Dizziness—Doxorubicin—uterine cancer	0.000381	0.00112	CcSEcCtD
Acetylcysteine—Nausea—Epirubicin—uterine cancer	0.00037	0.00109	CcSEcCtD
Acetylcysteine—Vomiting—Doxorubicin—uterine cancer	0.000366	0.00108	CcSEcCtD
Acetylcysteine—Rash—Doxorubicin—uterine cancer	0.000363	0.00107	CcSEcCtD
Acetylcysteine—Dermatitis—Doxorubicin—uterine cancer	0.000363	0.00107	CcSEcCtD
Acetylcysteine—Nausea—Doxorubicin—uterine cancer	0.000342	0.00101	CcSEcCtD
Acetylcysteine—IKBKB—Signaling by NGF—CDKN1B—uterine cancer	0.000152	0.000365	CbGpPWpGaD
Acetylcysteine—GRIN1—Neuronal System—HRAS—uterine cancer	0.000152	0.000365	CbGpPWpGaD
Acetylcysteine—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—PIK3CA—uterine cancer	0.000152	0.000364	CbGpPWpGaD
Acetylcysteine—GRIN1—Developmental Biology—CTNNB1—uterine cancer	0.000151	0.000363	CbGpPWpGaD
Acetylcysteine—CHUK—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	0.00015	0.000361	CbGpPWpGaD
Acetylcysteine—CHUK—Downstream signaling of activated FGFR—AKT1—uterine cancer	0.00015	0.00036	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—FGFR2—uterine cancer	0.000149	0.000358	CbGpPWpGaD
Acetylcysteine—CHUK—Integrated Breast Cancer Pathway—AKT1—uterine cancer	0.000148	0.000356	CbGpPWpGaD
Acetylcysteine—GRIN2B—Neuronal System—HRAS—uterine cancer	0.000148	0.000355	CbGpPWpGaD
Acetylcysteine—CHUK—B Cell Activation—PIK3CA—uterine cancer	0.000148	0.000355	CbGpPWpGaD
Acetylcysteine—SLC7A11—Hemostasis—PIK3CA—uterine cancer	0.000148	0.000355	CbGpPWpGaD
Acetylcysteine—CHUK—Fc epsilon receptor (FCERI) signaling—HRAS—uterine cancer	0.000148	0.000355	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by FGFR in disease—HRAS—uterine cancer	0.000148	0.000355	CbGpPWpGaD
Acetylcysteine—CHUK—DAP12 interactions—HRAS—uterine cancer	0.000148	0.000355	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by ERBB4—AKT1—uterine cancer	0.000148	0.000354	CbGpPWpGaD
Acetylcysteine—GRIN2B—Developmental Biology—CTNNB1—uterine cancer	0.000147	0.000354	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—INHBA—uterine cancer	0.000147	0.000352	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by EGFR—HRAS—uterine cancer	0.000147	0.000352	CbGpPWpGaD
Acetylcysteine—IKBKB—MAPK Signaling Pathway—TP53—uterine cancer	0.000146	0.000351	CbGpPWpGaD
Acetylcysteine—IKBKB—B Cell Activation—KRAS—uterine cancer	0.000146	0.00035	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—RNF43—uterine cancer	0.000146	0.000349	CbGpPWpGaD
Acetylcysteine—CHUK—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	0.000146	0.000349	CbGpPWpGaD
Acetylcysteine—IKBKB—Insulin Signaling—HRAS—uterine cancer	0.000145	0.000349	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—AKR1C3—uterine cancer	0.000145	0.000349	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by EGFR in Cancer—HRAS—uterine cancer	0.000145	0.000349	CbGpPWpGaD
Acetylcysteine—IKBKB—Fc epsilon receptor (FCERI) signaling—PIK3CA—uterine cancer	0.000145	0.000348	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by PDGF—HRAS—uterine cancer	0.000145	0.000347	CbGpPWpGaD
Acetylcysteine—IKBKB—Regulation of toll-like receptor signaling pathway—AKT1—uterine cancer	0.000144	0.000345	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—FGFR2—uterine cancer	0.000143	0.000344	CbGpPWpGaD
Acetylcysteine—SLC7A11—Hemostasis—TP53—uterine cancer	0.000143	0.000343	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—IRF1—uterine cancer	0.000142	0.000341	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—POLD1—uterine cancer	0.000142	0.00034	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—HMGA1—uterine cancer	0.000142	0.00034	CbGpPWpGaD
Acetylcysteine—CHUK—NGF signalling via TRKA from the plasma membrane—PIK3CA—uterine cancer	0.000142	0.00034	CbGpPWpGaD
Acetylcysteine—CHUK—Downstream signal transduction—AKT1—uterine cancer	0.000141	0.000338	CbGpPWpGaD
Acetylcysteine—GRIN1—Developmental Biology—EP300—uterine cancer	0.000141	0.000337	CbGpPWpGaD
Acetylcysteine—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—HRAS—uterine cancer	0.000141	0.000337	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—FBXW7—uterine cancer	0.00014	0.000337	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by FGFR—AKT1—uterine cancer	0.00014	0.000336	CbGpPWpGaD
Acetylcysteine—CHUK—Cytokine Signaling in Immune system—NRAS—uterine cancer	0.00014	0.000336	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling by NGF—PTEN—uterine cancer	0.00014	0.000336	CbGpPWpGaD
Acetylcysteine—IKBKB—BDNF signaling pathway—AKT1—uterine cancer	0.00014	0.000335	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by ERBB2—AKT1—uterine cancer	0.00014	0.000335	CbGpPWpGaD
Acetylcysteine—CHUK—DAP12 signaling—AKT1—uterine cancer	0.000139	0.000333	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by NGF—NRAS—uterine cancer	0.000138	0.00033	CbGpPWpGaD
Acetylcysteine—GRIN2B—Developmental Biology—EP300—uterine cancer	0.000137	0.000329	CbGpPWpGaD
Acetylcysteine—CHUK—B Cell Activation—HRAS—uterine cancer	0.000137	0.000328	CbGpPWpGaD
Acetylcysteine—SLC7A11—Hemostasis—HRAS—uterine cancer	0.000137	0.000328	CbGpPWpGaD
Acetylcysteine—CHUK—Downstream signaling events of B Cell Receptor (BCR)—AKT1—uterine cancer	0.000137	0.000328	CbGpPWpGaD
Acetylcysteine—GRIN1—Axon guidance—HRAS—uterine cancer	0.000135	0.000323	CbGpPWpGaD
Acetylcysteine—ACY1—Metabolism—PIK3CA—uterine cancer	0.000134	0.000322	CbGpPWpGaD
Acetylcysteine—IKBKB—B Cell Activation—PIK3CA—uterine cancer	0.000134	0.000322	CbGpPWpGaD
Acetylcysteine—IKBKB—Fc epsilon receptor (FCERI) signaling—HRAS—uterine cancer	0.000134	0.000322	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—INHBA—uterine cancer	0.000133	0.00032	CbGpPWpGaD
Acetylcysteine—GRIN1—Developmental Biology—VEGFA—uterine cancer	0.000133	0.000319	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—AKR1C1—uterine cancer	0.000133	0.000318	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—AKR1C1—uterine cancer	0.000132	0.000317	CbGpPWpGaD
Acetylcysteine—GRIN1—Developmental Biology—NRAS—uterine cancer	0.000132	0.000316	CbGpPWpGaD
Acetylcysteine—GRIN2B—Axon guidance—HRAS—uterine cancer	0.000131	0.000315	CbGpPWpGaD
Acetylcysteine—CHUK—NGF signalling via TRKA from the plasma membrane—HRAS—uterine cancer	0.000131	0.000314	CbGpPWpGaD
Acetylcysteine—CHUK—Fc epsilon receptor (FCERI) signaling—AKT1—uterine cancer	0.000131	0.000313	CbGpPWpGaD
Acetylcysteine—CHUK—DAP12 interactions—AKT1—uterine cancer	0.000131	0.000313	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by FGFR in disease—AKT1—uterine cancer	0.000131	0.000313	CbGpPWpGaD
Acetylcysteine—GRIN2B—Developmental Biology—VEGFA—uterine cancer	0.00013	0.000311	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—FBXW7—uterine cancer	0.00013	0.000311	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by EGFR—AKT1—uterine cancer	0.000129	0.000311	CbGpPWpGaD
Acetylcysteine—IKBKB—Insulin Signaling—AKT1—uterine cancer	0.000128	0.000308	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by EGFR in Cancer—AKT1—uterine cancer	0.000128	0.000308	CbGpPWpGaD
Acetylcysteine—GRIN2B—Developmental Biology—NRAS—uterine cancer	0.000128	0.000308	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by PDGF—AKT1—uterine cancer	0.000128	0.000306	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—FBXW7—uterine cancer	0.000127	0.000305	CbGpPWpGaD
Acetylcysteine—IKBKB—Cytokine Signaling in Immune system—NRAS—uterine cancer	0.000127	0.000305	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling by NGF—NRAS—uterine cancer	0.000125	0.0003	CbGpPWpGaD
Acetylcysteine—IKBKB—B Cell Activation—HRAS—uterine cancer	0.000124	0.000298	CbGpPWpGaD
Acetylcysteine—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—AKT1—uterine cancer	0.000124	0.000298	CbGpPWpGaD
Acetylcysteine—IKBKB—MAPK Signaling Pathway—AKT1—uterine cancer	0.000124	0.000296	CbGpPWpGaD
Acetylcysteine—CHUK—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	0.000123	0.000295	CbGpPWpGaD
Acetylcysteine—CHUK—B Cell Activation—AKT1—uterine cancer	0.000121	0.00029	CbGpPWpGaD
Acetylcysteine—SLC7A11—Hemostasis—AKT1—uterine cancer	0.000121	0.00029	CbGpPWpGaD
Acetylcysteine—CHUK—Cytokine Signaling in Immune system—KRAS—uterine cancer	0.000121	0.000289	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—AKR1C1—uterine cancer	0.00012	0.000288	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by NGF—KRAS—uterine cancer	0.000119	0.000284	CbGpPWpGaD
Acetylcysteine—IKBKB—Fc epsilon receptor (FCERI) signaling—AKT1—uterine cancer	0.000118	0.000284	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—RRM2—uterine cancer	0.000118	0.000284	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—CDH1—uterine cancer	0.000118	0.000282	CbGpPWpGaD
Acetylcysteine—CHUK—NGF signalling via TRKA from the plasma membrane—AKT1—uterine cancer	0.000116	0.000278	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—SOCS3—uterine cancer	0.000115	0.000276	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—DCN—uterine cancer	0.000115	0.000275	CbGpPWpGaD
Acetylcysteine—GRIN1—Developmental Biology—KRAS—uterine cancer	0.000113	0.000272	CbGpPWpGaD
Acetylcysteine—CHUK—Cytokine Signaling in Immune system—PIK3CA—uterine cancer	0.000111	0.000266	CbGpPWpGaD
Acetylcysteine—GRIN2B—Developmental Biology—KRAS—uterine cancer	0.00011	0.000265	CbGpPWpGaD
Acetylcysteine—ACY1—Metabolism—AKT1—uterine cancer	0.00011	0.000263	CbGpPWpGaD
Acetylcysteine—IKBKB—B Cell Activation—AKT1—uterine cancer	0.00011	0.000263	CbGpPWpGaD
Acetylcysteine—GSS—Metabolism—PTEN—uterine cancer	0.000109	0.000262	CbGpPWpGaD
Acetylcysteine—IKBKB—Cytokine Signaling in Immune system—KRAS—uterine cancer	0.000109	0.000262	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by NGF—PIK3CA—uterine cancer	0.000109	0.000261	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—CYP11A1—uterine cancer	0.000108	0.000259	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling by NGF—KRAS—uterine cancer	0.000108	0.000258	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—CDH1—uterine cancer	0.000107	0.000256	CbGpPWpGaD
Acetylcysteine—GSS—Metabolism—EP300—uterine cancer	0.000104	0.00025	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—SOCS3—uterine cancer	0.000104	0.00025	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—ERBB2—uterine cancer	0.000103	0.000248	CbGpPWpGaD
Acetylcysteine—CHUK—Cytokine Signaling in Immune system—HRAS—uterine cancer	0.000103	0.000246	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—AKR1C3—uterine cancer	0.000102	0.000245	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—AKR1C3—uterine cancer	0.000102	0.000244	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—CDKN2B—uterine cancer	0.000102	0.000244	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by NGF—HRAS—uterine cancer	0.000101	0.000242	CbGpPWpGaD
Acetylcysteine—IKBKB—Cytokine Signaling in Immune system—PIK3CA—uterine cancer	0.0001	0.000241	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—PGR—uterine cancer	9.93e-05	0.000238	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—ERBB2—uterine cancer	9.92e-05	0.000238	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling by NGF—PIK3CA—uterine cancer	9.88e-05	0.000237	CbGpPWpGaD
Acetylcysteine—GRIN1—Developmental Biology—HRAS—uterine cancer	9.63e-05	0.000231	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—FGFR2—uterine cancer	9.58e-05	0.00023	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—CDKN1B—uterine cancer	9.57e-05	0.000229	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—YWHAE—uterine cancer	9.47e-05	0.000227	CbGpPWpGaD
Acetylcysteine—GRIN2B—Developmental Biology—HRAS—uterine cancer	9.38e-05	0.000225	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—ERBB2—uterine cancer	9.37e-05	0.000225	CbGpPWpGaD
Acetylcysteine—IKBKB—Cytokine Signaling in Immune system—HRAS—uterine cancer	9.3e-05	0.000223	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—SMAD3—uterine cancer	9.27e-05	0.000222	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—AKR1C3—uterine cancer	9.24e-05	0.000222	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—CDKN1B—uterine cancer	9.19e-05	0.00022	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling by NGF—HRAS—uterine cancer	9.14e-05	0.000219	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—FBXW7—uterine cancer	9.08e-05	0.000218	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—CTNNB1—uterine cancer	9.04e-05	0.000217	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—PGR—uterine cancer	9e-05	0.000216	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—ERBB2—uterine cancer	8.99e-05	0.000216	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by NGF—AKT1—uterine cancer	8.9e-05	0.000213	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—FGFR2—uterine cancer	8.85e-05	0.000212	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—PTEN—uterine cancer	8.81e-05	0.000211	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—FGFR2—uterine cancer	8.69e-05	0.000208	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—CDKN1B—uterine cancer	8.68e-05	0.000208	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—YWHAE—uterine cancer	8.59e-05	0.000206	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—MTHFR—uterine cancer	8.52e-05	0.000204	CbGpPWpGaD
Acetylcysteine—GRIN1—Developmental Biology—AKT1—uterine cancer	8.5e-05	0.000204	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—PTEN—uterine cancer	8.46e-05	0.000203	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—EP300—uterine cancer	8.4e-05	0.000201	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—CDKN1B—uterine cancer	8.33e-05	0.0002	CbGpPWpGaD
Acetylcysteine—GRIN2B—Developmental Biology—AKT1—uterine cancer	8.29e-05	0.000199	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—FBXW7—uterine cancer	8.23e-05	0.000197	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—CTNNB1—uterine cancer	8.2e-05	0.000197	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling by NGF—AKT1—uterine cancer	8.07e-05	0.000194	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—PTEN—uterine cancer	7.99e-05	0.000192	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—STK11—uterine cancer	7.96e-05	0.000191	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—CYP19A1—uterine cancer	7.96e-05	0.000191	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—STK11—uterine cancer	7.94e-05	0.00019	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—NRAS—uterine cancer	7.86e-05	0.000188	CbGpPWpGaD
Acetylcysteine—GSS—Metabolism—PIK3CA—uterine cancer	7.72e-05	0.000185	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—PTEN—uterine cancer	7.67e-05	0.000184	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—EP300—uterine cancer	7.62e-05	0.000183	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—NRAS—uterine cancer	7.55e-05	0.000181	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	7.47e-05	0.000179	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—SOCS3—uterine cancer	7.43e-05	0.000178	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—STK11—uterine cancer	7.2e-05	0.000173	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—CDH1—uterine cancer	7.13e-05	0.000171	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—NRAS—uterine cancer	7.13e-05	0.000171	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	7.13e-05	0.000171	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—CDKN2B—uterine cancer	7.11e-05	0.000171	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—IGF1R—uterine cancer	6.91e-05	0.000166	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—NRAS—uterine cancer	6.84e-05	0.000164	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—KRAS—uterine cancer	6.76e-05	0.000162	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—SOCS3—uterine cancer	6.74e-05	0.000162	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—KRAS—uterine cancer	6.5e-05	0.000156	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—SMAD3—uterine cancer	6.49e-05	0.000156	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—CDH1—uterine cancer	6.47e-05	0.000155	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CDKN2B—uterine cancer	6.45e-05	0.000155	CbGpPWpGaD
Acetylcysteine—GSS—Metabolism—AKT1—uterine cancer	6.3e-05	0.000151	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—IGF1R—uterine cancer	6.26e-05	0.00015	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—PIK3CA—uterine cancer	6.21e-05	0.000149	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—FGFR2—uterine cancer	6.19e-05	0.000149	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—KRAS—uterine cancer	6.13e-05	0.000147	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—ERBB2—uterine cancer	6.02e-05	0.000144	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—MTHFR—uterine cancer	5.98e-05	0.000143	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—PIK3CA—uterine cancer	5.97e-05	0.000143	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—KRAS—uterine cancer	5.89e-05	0.000141	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—SMAD3—uterine cancer	5.89e-05	0.000141	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—HRAS—uterine cancer	5.75e-05	0.000138	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—PIK3CA—uterine cancer	5.64e-05	0.000135	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—FGFR2—uterine cancer	5.62e-05	0.000135	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—CDKN1B—uterine cancer	5.57e-05	0.000134	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—ERBB2—uterine cancer	5.56e-05	0.000133	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—HRAS—uterine cancer	5.52e-05	0.000132	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—ERBB2—uterine cancer	5.46e-05	0.000131	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—PIK3CA—uterine cancer	5.41e-05	0.00013	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—ESR1—uterine cancer	5.3e-05	0.000127	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	5.27e-05	0.000126	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—CTNNB1—uterine cancer	5.26e-05	0.000126	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—HRAS—uterine cancer	5.21e-05	0.000125	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—CDKN1B—uterine cancer	5.14e-05	0.000123	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—PTEN—uterine cancer	5.13e-05	0.000123	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—AKT1—uterine cancer	5.08e-05	0.000122	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—CDKN1B—uterine cancer	5.05e-05	0.000121	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—HRAS—uterine cancer	5.01e-05	0.00012	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—EP300—uterine cancer	4.89e-05	0.000117	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—AKT1—uterine cancer	4.88e-05	0.000117	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—CTNNB1—uterine cancer	4.86e-05	0.000117	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—ESR1—uterine cancer	4.81e-05	0.000115	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—CTNNB1—uterine cancer	4.77e-05	0.000114	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—PTEN—uterine cancer	4.74e-05	0.000114	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—CCL2—uterine cancer	4.67e-05	0.000112	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—PTEN—uterine cancer	4.65e-05	0.000112	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—AKT1—uterine cancer	4.6e-05	0.00011	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—NRAS—uterine cancer	4.58e-05	0.00011	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—EP300—uterine cancer	4.52e-05	0.000108	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—EP300—uterine cancer	4.44e-05	0.000106	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—AKT1—uterine cancer	4.42e-05	0.000106	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CCL2—uterine cancer	4.23e-05	0.000101	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—NRAS—uterine cancer	4.23e-05	0.000101	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—NRAS—uterine cancer	4.15e-05	9.95e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—KRAS—uterine cancer	3.94e-05	9.45e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—ERBB2—uterine cancer	3.89e-05	9.33e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—CXCL8—uterine cancer	3.69e-05	8.85e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—KRAS—uterine cancer	3.64e-05	8.72e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—PIK3CA—uterine cancer	3.62e-05	8.68e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—CDKN1B—uterine cancer	3.6e-05	8.64e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—KRAS—uterine cancer	3.57e-05	8.57e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—ERBB2—uterine cancer	3.53e-05	8.46e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—CTNNB1—uterine cancer	3.4e-05	8.16e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—HRAS—uterine cancer	3.35e-05	8.03e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CXCL8—uterine cancer	3.35e-05	8.02e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—PIK3CA—uterine cancer	3.34e-05	8.01e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—PTEN—uterine cancer	3.33e-05	7.98e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—PTEN—uterine cancer	3.32e-05	7.96e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—PIK3CA—uterine cancer	3.28e-05	7.87e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CDKN1B—uterine cancer	3.27e-05	7.83e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—EP300—uterine cancer	3.17e-05	7.61e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—EP300—uterine cancer	3.16e-05	7.59e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—HRAS—uterine cancer	3.09e-05	7.42e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CTNNB1—uterine cancer	3.09e-05	7.4e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—HRAS—uterine cancer	3.04e-05	7.28e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—PTEN—uterine cancer	3.01e-05	7.21e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—VEGFA—uterine cancer	3e-05	7.19e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—NRAS—uterine cancer	2.96e-05	7.1e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—AKT1—uterine cancer	2.96e-05	7.09e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—EP300—uterine cancer	2.87e-05	6.88e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—AKT1—uterine cancer	2.73e-05	6.55e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—VEGFA—uterine cancer	2.72e-05	6.52e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—NRAS—uterine cancer	2.68e-05	6.44e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—AKT1—uterine cancer	2.68e-05	6.43e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—KRAS—uterine cancer	2.55e-05	6.11e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—PIK3CA—uterine cancer	2.35e-05	5.63e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—PIK3CA—uterine cancer	2.34e-05	5.61e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—KRAS—uterine cancer	2.31e-05	5.54e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—TP53—uterine cancer	2.26e-05	5.43e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—HRAS—uterine cancer	2.17e-05	5.19e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—PIK3CA—uterine cancer	2.12e-05	5.09e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—TP53—uterine cancer	2.05e-05	4.92e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—HRAS—uterine cancer	1.96e-05	4.71e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—AKT1—uterine cancer	1.92e-05	4.6e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—AKT1—uterine cancer	1.91e-05	4.58e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—AKT1—uterine cancer	1.73e-05	4.16e-05	CbGpPWpGaD
